Innovative Idea Generating Centre
REVOLUTIONIZING PHARMACOVIGILANCE AND RISK MANAGEMENT CONFERENCE
Exploring innovative pharmacovigilance approaches to enhance patient safety, optimize risk management, and ensure regulatory compliance worldwide.
25 JUNE 2025 | VIRTUAL CONGRESS(BST)
Pharmacovigilance (PV) and risk management are integral components of drug safety and regulatory compliance. The ever-evolving landscape of pharmaceuticals, biologics, and medical devices demands continuous adaptation to emerging safety concerns, regulatory updates, and technological advancements. The "Revolutionizing Pharmacovigilance and Risk Management" Conference 2025 aims to bring together key stakeholders, industry leaders, regulatory authorities, healthcare professionals, and technology innovators to discuss and shape the future of pharmacovigilance.
Addressing Global Pharmacovigilance Challenges
In recent years, the pharmaceutical industry has faced numerous challenges, including increased regulatory scrutiny, growing patient awareness, and the need for real-world evidence (RWE) to support drug safety decisions. The conference will provide a platform to discuss critical challenges such as:
- Regulatory Complexity: Understanding and complying with diverse global pharmacovigilance regulations.
- Technological Advancements: The integration of artificial intelligence (AI), machine learning (ML), and automation in PV processes.
- Data Management & Real-World Evidence: Leveraging big data and real-world evidence for better decision-making.
- Patient-Centric Pharmacovigilance: Engaging patients in adverse event reporting and monitoring.
- Global Safety Concerns: Addressing emerging safety signals and rapid responses to adverse drug reactions (ADRs).
Facilitating Knowledge Exchange and Best Practices
The conference aims to facilitate knowledge sharing among experts and industry professionals by featuring:
Keynote addresses from global leaders in pharmacovigilance.
Panel discussions on regulatory updates from agencies like the FDA, EMA, MHRA, and WHO.
Case studies on successful risk management strategies.
Workshops on implementing AI and automation in PV operations.
Embracing Technological Innovation
The rise of digital health, AI-driven safety monitoring, and blockchain for data security presents opportunities to enhance pharmacovigilance efficiency. This conference will highlight:
- The role of AI and predictive analytics in adverse event detection.
- Automation in case processing and signal detection.
- Blockchain technology for secure and transparent data sharing.
- The potential of mobile health (mHealth) applications in pharmacovigilance.
Strengthening Regulatory Compliance
Pharmacovigilance regulations continue to evolve, requiring companies to stay updated to ensure compliance. The conference will help stakeholders understand:
- Recent changes in international PV regulations.
- Best practices for complying with Good Pharmacovigilance Practices (GVP).
- The impact of regulatory changes on pharmaceutical business strategies.
Enhancing Patient Safety and Public Health
At its core, pharmacovigilance is about ensuring patient safety and improving public health outcomes. Through expert discussions and collaborative sessions, the conference will:
- Promote proactive risk management strategies.
- Encourage transparent and effective communication with healthcare providers and patients.
- Foster partnerships to enhance global drug safety monitoring.
Strengthening Industry Collaborations and Networking
The conference will serve as a hub for collaboration, bringing together key players in the pharmacovigilance ecosystem, including:
- Pharmaceutical companies and biotechnology firms.
- Regulatory agencies and policymakers.
- Healthcare providers and patient advocacy groups.
- Technology providers offering innovative PV solutions.
The Revolutionizing Pharmacovigilance and Risk Management Conference 2025 is essential in fostering innovation, ensuring compliance, and improving patient safety. By providing a platform for industry experts, regulators, and technology innovators to exchange ideas, discuss challenges, and collaborate on solutions, this conference will drive the future of pharmacovigilance forward. Through knowledge sharing, regulatory discussions, and the integration of cutting-edge technologies, this event will play a pivotal role in shaping the next era of drug safety and risk management.
Who should attend:
Pharmacovigilance & Drug Safety
Head/Director/VP of Pharmacovigilance
- Drug Safety Officer/Specialist Pharmacovigilance
- Scientist Risk Management
- Specialist Signal Detection & Management
- Lead Safety Surveillance Manager
Regulatory Affairs & Compliance
- Regulatory Affairs Manager/Director
- Compliance Officer/Manager
- Regulatory Intelligence Specialist
- Quality Assurance Manager
- Clinical Safety & Compliance Director
Clinical Research & Development
- Clinical Research Associate (CRA)
- Clinical Trial Safety Specialist
- Medical Monitor
- Clinical Data Manager
Medical Affairs & Risk Management
- Chief Medical Officer (CMO)
- Medical Director Risk Evaluation & Mitigation Strategies (REMS)
- Lead Epidemiologist
- Technology & Data Science in PV Drug Safety
- Data Analyst AI & Automation Specialist in PV
- Signal Detection & Data Science Lead
©Copyright. All rights reserved.
We need your consent to load the translations
We use a third-party service to translate the website content that may collect data about your activity. Please review the details in the privacy policy and accept the service to view the translations.